HCC - HEPATOCELLULAR CARCINOMA
Clinical trials for HCC - HEPATOCELLULAR CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HCC - HEPATOCELLULAR CARCINOMA trials appear
Sign up with your email to follow new studies for HCC - HEPATOCELLULAR CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Triple-Threat attack on tough liver cancer shows promise
Disease control OngoingThis study is looking at a three-part treatment for people with intermediate to advanced liver cancer who cannot have surgery. It combines a procedure to cut off the tumor's blood supply and deliver chemo, followed by precise radiation and a drug that helps the immune system figh…
Matched conditions: HCC - HEPATOCELLULAR CARCINOMA
Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New cancer drug trial tests immune system 'Decoy' to fight advanced tumors
Disease control OngoingThis early-stage study is testing a new immunotherapy drug called DECOY20, both alone and combined with another cancer drug (tislelizumab), in people with advanced solid tumors that have stopped responding to standard treatments. The main goals are to find safe doses, check for s…
Matched conditions: HCC - HEPATOCELLULAR CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Indaptus Therapeutics, Inc • Aim: Disease control
Last updated Mar 16, 2026 15:24 UTC
-
AI steps in: can a computer predict where liver cancer will spread next?
Knowledge-focused OngoingThis study is testing a computer model designed to predict which liver cancer patients are most likely to have their cancer spread to other organs like the lungs or bones after initial treatment. It will follow 800 patients after their treatment to see how accurate the model's pr…
Matched conditions: HCC - HEPATOCELLULAR CARCINOMA
Sponsor: Tongji Hospital • Aim: Knowledge-focused
Last updated Mar 19, 2026 14:56 UTC